Advanced Medical Solutions Group (FRA:AQA) ROC % : 2.76% (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Advanced Medical Solutions Group ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Advanced Medical Solutions Group's annualized return on capital (ROC %) for the quarter that ended in Jun. 2024 was 2.76%.

As of today (2024-09-21), Advanced Medical Solutions Group's WACC % is 8.50%. Advanced Medical Solutions Group's ROC % is 4.41% (calculated using TTM income statement data). Advanced Medical Solutions Group earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Advanced Medical Solutions Group ROC % Historical Data

The historical data trend for Advanced Medical Solutions Group's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Medical Solutions Group ROC % Chart

Advanced Medical Solutions Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROC %

Get a 7-Day Free Trial

15.07

5.86

11.02

10.98

7.15

Advanced Medical Solutions Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROC %	Get a 7-Day Free Trial															11.37	11.22	8.22	6.07	2.76

Advanced Medical Solutions Group ROC % Calculation

Advanced Medical Solutions Group's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2023 is calculated as:

	ROC % (A: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (A: Dec. 2022 )	+	Invested Capital (A: Dec. 2023 ))	/ count )
=	21.917 * ( 1 - 24.9% )	/	( (213.992	+	246.673)	/ 2 )
=	16.459667	/	230.3325
=	7.15 %

where

	Invested Capital		(A: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	323.207	-	14.629	-	( 94.586	-	max(0, 26.076	-	151.672	+	94.586	))
=	213.992

	Invested Capital		(A: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	335.658	-	19.154	-	( 69.831	-	max(0, 25.053	-	141.986	+	69.831	))
=	246.673

Advanced Medical Solutions Group's annualized Return on Capital (ROC %) for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	9.32 * ( 1 - 26.67% )	/	( (246.673	+	248.423)	/ 2 )
=	6.834356	/	247.548
=	2.76 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	335.658	-	19.154	-	( 69.831	-	max(0, 25.053	-	141.986	+	69.831	))
=	246.673

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	434.698	-	26.78	-	( 159.495	-	max(0, 28.593	-	239.934	+	159.495	))
=	248.423

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

Advanced Medical Solutions Group (FRA:AQA) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Advanced Medical Solutions Group's WACC % is 8.50%. Advanced Medical Solutions Group's ROC % is 4.41% (calculated using TTM income statement data). Advanced Medical Solutions Group earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Advanced Medical Solutions Group ROC % Related Terms

Thank you for viewing the detailed overview of Advanced Medical Solutions Group's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Medical Solutions Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Medical Solutions Group PLC (FRA:AQA) » Definitions » ROC %

Comparable Companies

Traded in Other Exchanges

AMS.GB:UK AMS:UK

Address

Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT

Website

https://www.admedsol.com

U.K.-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.

Advanced Medical Solutions Group Headlines

No Headlines